HPC
AZN icon

HM Payson & Co’s AstraZeneca AZN Stock Holding History

HM Payson & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Sell
20,928
-3,063
-13% -$576K 0.05% 138
2026
Q1 		$4.73M Sell
23,991
-1,768
-7% -$341K 0.07% 121
2025
Q4 		$4.74M Buy
25,759
+9,473
+58% +$1.66M 0.07% 116
2025
Q3 		$2.5M Sell
16,286
-1,229
-7% -$186K 0.04% 143
2025
Q2 		$2.45M Sell
17,515
-10,152
-37% -$1.42M 0.04% 141
2025
Q1 		$4.07M Buy
27,667
+24,886
+895% +$3.6M 0.07% 112
2024
Q4 		$364K Sell
2,781
-29,976
-92% -$4.2M 0.01% 322
2024
Q3 		$5.1M Buy
32,757
+30,902
+1,666% +$4.99M 0.09% 108
2024
Q2 		$289K Buy
1,855
+7
+0.4% +$1.05K 0.01% 349
2024
Q1 		$250K Buy
1,848
+3
+0.2% +$397 ﹤0.01% 362
2023
Q4 		$249K Sell
1,845
-469
-20% -$61K 0.01% 352
2023
Q3 		$313K Buy
2,314
+1,134
+96% +$155K 0.01% 319
2023
Q2 		$169K Buy
1,180
+140
+13% +$20.6K ﹤0.01% 395
2023
Q1 		$144K Sell
1,040
-11
-1% -$1.48K ﹤0.01% 417
2022
Q4 		$143K Buy
1,051
+39
+4% +$4.89K ﹤0.01% 415
2022
Q3 		$111K Hold
1,012
– – ﹤0.01% 451
2022
Q2 		$134K Sell
1,012
-115
-10% -$15.1K ﹤0.01% 428
2022
Q1 		$149K Buy
1,127
+1,000
+787% +$120K ﹤0.01% 434
2021
Q4 		$15K Hold
127
– – ﹤0.01% 811
2021
Q3 		$15K Hold
127
– – ﹤0.01% 782
2021
Q2 		$15K Sell
127
-263
-67% -$28.9K ﹤0.01% 784
2021
Q1 		$39K Sell
390
-509
-57% -$51.2K ﹤0.01% 641
2020
Q4 		$90K Buy
899
+624
+227% +$66.1K ﹤0.01% 491
2020
Q3 		$30K Buy
+275
New +$30.6K ﹤0.01% 653

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HM Payson & Co's AZN Position: Q2 2026 in Review

HM Payson & Co reduced its AstraZeneca (AZN) stake by 13% in Q2 2026, selling an estimated $576K and leaving 20,928 shares worth $3.97M. The position accounts for 0.05% of the portfolio, ranked #138.

HM Payson & Co first reported a position in AZN in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.1M in Q3 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • HM Payson & Co held 20,928 shares of AstraZeneca worth $3.97M as of Q2 2026.
  • HM Payson & Co sold 3,063 AstraZeneca shares in Q2 2026, an estimated $576K.
  • AstraZeneca made up 0.05% of HM Payson & Co's portfolio in Q2 2026, its #138 holding.
  • HM Payson & Co first reported a position in AstraZeneca in Q3 2020 and has held it in 24 quarters since.
  • HM Payson & Co's AstraZeneca position peaked at $5.1M in Q3 2024.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.